Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.22.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Revenue $ 5,224 $ 3,477
Cost of sales (3,186) (1,337)
Gross profit 2,038 2,140
Expenses    
General and administrative 8,261 8,464
Sales and marketing 733 587
Research and development 412 278
Restructuring expenses 4,008 0
Depreciation and amortization 517 579
Total expenses 13,931 9,908
Loss from operations (11,893) (7,768)
Other Expense (Income), net    
Interest and amortization of debt issuance cost 2,118 978
(Gain) loss on remeasurement of warrant liability (490) 4,851
Loss on debt extinguishment 2,263 0
Foreign exchange loss 345 759
Other income, net (53) (602)
Total other expenses, net 4,183 5,986
Loss before income taxes and equity investment loss (16,076) (13,754)
Equity investment share of loss 64 11
Net loss $ (16,140) $ (13,765)
Net loss per share - basic (USD per share) $ (0.58) $ (0.55)
Net loss per share - diluted (USD per share) $ (0.58) $ (0.55)
Weighted-average common shares outstanding - basic (in shares) 27,960,584 25,030,080
Weighted-average common shares outstanding - diluted (in shares) 27,960,584 25,030,080